Free Trial

Sendero Wealth Management LLC Has $5.22 Million Holdings in Centene Co. (NYSE:CNC)

Centene logo with Medical background

Sendero Wealth Management LLC boosted its stake in Centene Co. (NYSE:CNC - Free Report) by 5.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 86,014 shares of the company's stock after purchasing an additional 4,666 shares during the period. Sendero Wealth Management LLC's holdings in Centene were worth $5,222,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Stratos Wealth Partners LTD. lifted its stake in shares of Centene by 4.1% in the 4th quarter. Stratos Wealth Partners LTD. now owns 4,094 shares of the company's stock valued at $248,000 after acquiring an additional 163 shares during the last quarter. MassMutual Private Wealth & Trust FSB raised its position in Centene by 8.8% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 2,092 shares of the company's stock valued at $127,000 after purchasing an additional 169 shares during the last quarter. Capital Advisors Ltd. LLC raised its holdings in Centene by 75.3% in the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company's stock valued at $25,000 after buying an additional 177 shares during the last quarter. Private Trust Co. NA boosted its position in Centene by 23.7% during the 4th quarter. Private Trust Co. NA now owns 956 shares of the company's stock worth $58,000 after buying an additional 183 shares during the period. Finally, Howard Capital Management Inc. grew its holdings in Centene by 5.4% during the 4th quarter. Howard Capital Management Inc. now owns 3,591 shares of the company's stock worth $218,000 after acquiring an additional 184 shares during the last quarter. Institutional investors and hedge funds own 93.63% of the company's stock.

Centene Trading Down 0.2%

Shares of CNC stock traded down $0.14 during trading hours on Thursday, hitting $54.80. 4,003,140 shares of the company were exchanged, compared to its average volume of 4,882,030. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.10 and a current ratio of 1.11. Centene Co. has a fifty-two week low of $54.01 and a fifty-two week high of $80.59. The company has a 50 day simple moving average of $60.19 and a two-hundred day simple moving average of $60.13. The firm has a market cap of $27.27 billion, a P/E ratio of 8.78, a P/E/G ratio of 0.80 and a beta of 0.48.

Centene (NYSE:CNC - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $2.90 earnings per share for the quarter, beating the consensus estimate of $2.52 by $0.38. The firm had revenue of $46.62 billion for the quarter, compared to analyst estimates of $43.16 billion. Centene had a net margin of 2.03% and a return on equity of 13.85%. The business's quarterly revenue was up 15.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.26 earnings per share. Equities analysts anticipate that Centene Co. will post 6.86 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have recently issued reports on CNC shares. Guggenheim reaffirmed a "neutral" rating on shares of Centene in a research note on Tuesday, April 29th. Wells Fargo & Company lowered their target price on Centene from $76.00 to $72.00 and set an "overweight" rating for the company in a research report on Friday, February 14th. Jefferies Financial Group reduced their price target on Centene from $64.00 to $61.00 and set a "hold" rating on the stock in a research report on Tuesday, April 29th. Argus cut Centene from a "buy" rating to a "hold" rating in a research note on Thursday, February 6th. Finally, Barclays restated an "equal weight" rating and set a $65.00 price objective (down from $84.00) on shares of Centene in a research report on Monday. Seven investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Centene has an average rating of "Moderate Buy" and a consensus target price of $78.31.

Read Our Latest Analysis on CNC

About Centene

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Read More

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Should You Invest $1,000 in Centene Right Now?

Before you consider Centene, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.

While Centene currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines